Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Oportun Financial (OPRT) Research & Development (2018 - 2025)

Oportun Financial (OPRT) has disclosed Research & Development for 8 consecutive years, with $16.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 6.78% year-over-year to $16.1 million, compared with a TTM value of $70.6 million through Dec 2025, up 5.41%, and an annual FY2025 reading of $70.6 million, up 5.41% over the prior year.
  • Research & Development was $16.1 million for Q4 2025 at Oportun Financial, down from $16.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $37.1 million in Q4 2021 and bottomed at $16.0 million in Q1 2024.
  • Average Research & Development over 5 years is $22.0 million, with a median of $19.2 million recorded in 2023.
  • The sharpest move saw Research & Development surged 55.69% in 2021, then tumbled 44.47% in 2023.
  • Year by year, Research & Development stood at $37.1 million in 2021, then crashed by 42.53% to $21.3 million in 2022, then decreased by 15.41% to $18.1 million in 2023, then fell by 4.13% to $17.3 million in 2024, then fell by 6.78% to $16.1 million in 2025.
  • Business Quant data shows Research & Development for OPRT at $16.1 million in Q4 2025, $16.5 million in Q3 2025, and $18.1 million in Q2 2025.